DJ Abbott Laboratories Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories $(ABT)$ slipped 1.78% to $103.36 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,591.70 and Dow Jones Industrial Average falling 0.60% to 52,064.10.

This was the stock's fifth consecutive day of losses.

Abbott Laboratories closed 24.82% below its 52-week high of $137.49, which the company reached on September 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.27% to $266.35, Pfizer Inc. $(PFE)$ fell 0.47% to $27.65, and Merck & Co. Inc. (MRK) fell 1.91% to $144.71.

Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.